Suppr超能文献

特发性儿童肾病综合征行肾活检的适应证。

Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.

机构信息

Division of Nephrology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

British Columbia Children's Hospital, 4480 Oak Street, Room K4-150, Vancouver, BC, V6H 2V2, Canada.

出版信息

Pediatr Nephrol. 2017 Oct;32(10):1897-1905. doi: 10.1007/s00467-017-3687-3. Epub 2017 May 24.

Abstract

BACKGROUND

Most cases of childhood nephrotic syndrome (NS) are due to minimal change disease (MCD), while a minority of children have focal segmental glomerulosclerosis (FSGS) and an unfavorable clinical course, requiring a kidney biopsy to confirm diagnosis. We hypothesized that clinical characteristics at diagnosis and initial response to corticosteroid treatment accurately predict FSGS and can be used to guide consistent practice in the indications for kidney biopsy.

METHODS

This was a case control study (1990-2012). Inclusion criteria included age 1-17 years, meeting the diagnostic criteria for NS, and having biopsy-proven FSGS or MCD. Clinical characteristics at diagnosis included age, kidney function [estimated glomerular filtration rate (eGFR)], hypertension, hematuria, nephritis (reduced eGFR, hematuria, hypertension), and response to steroids.

RESULTS

From a total of 169 children who underwent kidney biopsy for NS we included 65 children with MCD and 22 with FSGS for analysis. There were no significant between-group differences in age, sex, or eGFR at the time of diagnosis. The FSGS group had a higher proportion of hypertension (40 vs. 15%; p = 0.02), hematuria (80 vs. 47%; p = 0.01), and nephritis (22 vs. 2%; p = 0.004) and was more likely to be steroid resistant after 6 weeks of treatment than the MCD group (67 vs. 19%; p < 0.001). As predictors of FSGS, hematuria had a high sensitivity of 0.80 [95% confidence interval (CI) 0.56-0.93] and low specificity of 0.53 (95% CI 0.39-0.66), nephritis had a low sensitivity of 0.22 (95% CI 0.07-0.48) and high specificity of 0.98 (95% CI 0.88-0.99), and steroid resistance had a low sensitivity of 0.67 (95% CI 0.43-0.85) and high specificity of 0.81 (95% CI 0.68-0.90). The combination of steroid resistance after 6 weeks of therapy and/or nephritis at diagnosis yielded the optimal sensitivity and specificity at 0.80 (95% CI 0.56-0.93) and 0.75 (95% CI 0.60-0.86), respectively, confirmed by the highest receiver operator characteristic area under the curve of 0.77.

CONCLUSION

Steroid resistance after 6 weeks of therapy and/or nephritis at initial presentation is an accurate predictor of FSGS in children with NS and will be used as the indication for kidney biopsy in our newly developed clinical pathway. This approach will maximize the yield of diagnostic FSGS biopsies while minimizing the number of unnecessary MCD biopsies.

摘要

背景

大多数儿童肾病综合征(NS)病例是由微小病变病(MCD)引起的,而少数儿童有局灶节段性肾小球硬化症(FSGS)和不良的临床病程,需要进行肾活检以确诊。我们假设在诊断时的临床特征和初始对皮质类固醇治疗的反应可以准确预测 FSGS,并可用于指导在肾活检指征方面的一致实践。

方法

这是一项病例对照研究(1990-2012 年)。纳入标准包括年龄 1-17 岁,符合 NS 的诊断标准,且经活检证实为 FSGS 或 MCD。诊断时的临床特征包括年龄、肾功能[估计肾小球滤过率(eGFR)]、高血压、血尿、肾炎(肾小球滤过率降低、血尿、高血压)以及对类固醇的反应。

结果

在总共 169 名因 NS 而行肾活检的儿童中,我们纳入了 65 名 MCD 患儿和 22 名 FSGS 患儿进行分析。两组在诊断时的年龄、性别或 eGFR 方面无显著差异。FSGS 组高血压(40%比 15%;p=0.02)、血尿(80%比 47%;p=0.01)和肾炎(22%比 2%;p=0.004)的比例更高,且在 6 周治疗后对皮质类固醇的耐药性更高(67%比 19%;p<0.001)。血尿作为 FSGS 的预测指标,其灵敏度为 0.80[95%置信区间(CI)0.56-0.93],特异性为 0.53(95% CI 0.39-0.66);肾炎的灵敏度为 0.22(95% CI 0.07-0.48),特异性为 0.98(95% CI 0.88-0.99);皮质类固醇耐药性的灵敏度为 0.67(95% CI 0.43-0.85),特异性为 0.81(95% CI 0.68-0.90)。6 周治疗后皮质类固醇耐药性和/或诊断时肾炎的组合具有最佳的灵敏度和特异性,分别为 0.80(95% CI 0.56-0.93)和 0.75(95% CI 0.60-0.86),这在受试者工作特征曲线下面积为 0.77 时得到了证实。

结论

6 周治疗后皮质类固醇耐药性和/或初始表现时肾炎是儿童 NS 中 FSGS 的准确预测指标,将作为我们新制定的临床路径中肾活检的指征。这种方法将最大限度地提高 FSGS 活检的阳性率,同时最大限度地减少不必要的 MCD 活检数量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验